Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Edgewise Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
EWTX
Nasdaq
2830
www.edgewisetx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Edgewise Therapeutics, Inc.
Why Is Andreas Halvorsen Bullish On Edgewise Therapeutics, Inc. (EWTX) Now?
- Jan 23rd, 2025 6:37 am
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
- Jan 22nd, 2025 1:00 pm
Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans
- Jan 17th, 2025 2:19 pm
Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
- Jan 13th, 2025 1:00 pm
Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
- Jan 7th, 2025 1:00 pm
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains
- Dec 18th, 2024 2:23 pm
EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study
- Dec 17th, 2024 2:18 pm
Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease
- Dec 16th, 2024 4:56 pm
Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
- Dec 16th, 2024 11:00 am
Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
- Dec 5th, 2024 7:32 pm
Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
- Nov 26th, 2024 11:00 am
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Nov 7th, 2024 1:00 pm
Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now
- Oct 7th, 2024 9:37 pm
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
- Oct 1st, 2024 12:00 pm
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
- Sep 20th, 2024 11:28 am
Company News for Sep 20, 2024
- Sep 20th, 2024 9:05 am
Edgewise’s EDG-7500 shows benefit in two obstructive HCM trials
- Sep 20th, 2024 8:52 am
How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart Disease
- Sep 19th, 2024 8:08 pm
Why Edgewise Therapeutics Stock Is Up 50% on Thursday
- Sep 19th, 2024 4:55 pm
EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies
- Sep 19th, 2024 3:59 pm
Scroll